Trial drug overcomes resistant chronic myeloid leukemiaOmacetaxine battles genetic mutation that negates existing therapy Paroxetine cuts tamoxifen effectiveness in breast cancerOntario study links the drug combo with increased mortality Prostate biopsy complication rate rising Canadian data reveal most hospital admissions for these adverse events are due to infections Chemo- trastuzumab combo ups survival Study finds no difference in adjuvant therapy strategies Continuous aromatase inhibitor therapy no better than starting with tamoxifen Adjuvant therapy has feverish results in real-world care Febrile neutropenia observed at higher than expected rate FPs should take lead in reducing breast cancer risk Online tool helps family doctors screen women to detect higher-risk patients Rethinking breast cancer Wait times for diagnosis exceed accepted targets Nilotinib bests imatinib in chronic myeloid leukemia Questions about tolerability and cost of treatment need answering before clinical practice should change First Previous 74 75 76 77 78 Next Last
